Silvain, Johanne
,
O’Connor, Stephen A.
Yan, Yan
Kerneis, Mathieu
Hauguel-Moreau, Marie
Zeitouni, Michel
Overtchouk, Pavel
Ankri, Annick
Brugier, Delphine
Vicaut, Eric
Ecollan, Patrick
Galier, Sophie
Collet, Jean-Philippe
Montalescot, Gilles
Funding for this research was provided by:
Action Coeur
Sanofi-Aventis
Article History
First Online: 25 August 2018
Compliance with Ethical Standards
:
: This study was supported by Sanofi-Aventis and ACTION Study Group, ExternalRef removed.
: J Silvain has received research grants, honorarium or travel support from Actelion, Amed, Amgen, Algorythm, Astra-Zeneca, Bayer, Daiichi-Sankyo, Eli Lilly, Fondation de France, Gilead Science, Iroko Cardio, Sanofi-Aventis and Saint-Jude Medical; M. Kerneis has received research grants from Sanofi, Fédération Française de Cardiologie, and Société Française de Cardiologie, and lectures and consulting fees from ESC, AstraZeneca, Daiichi-Sankyo, and Bayer; E. Vicaut has received research grants from Boehringer, Pfizer, Sanofi, LFB, Abbott, Fresenius, Medtronic, Hexacath, CERC, Novartis, and Elli Lilly; J.P. Collet has received research grants or honorarium from AstraZeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, Eli-Lilly, Fédération Française de Cardiologie, Lead-Up, Medtronic, MSD, Sanofi-Aventis, and WebMD; G. Montalescot has received research grants or honorarium from ADIR, Amgen, AstraZeneca, Bayer, Berlin Chimie AG, Boehringer Ingelheim, Bristol-Myers Squibb, Beth Israel Deaconess Medical, Brigham Women’s Hospital, Cardiovascular Research Foundation, Celladon, CME Resources, Daiichi-Sankyo, Eli-Lilly, Europa, Elsevier, Fédération Française de Cardiologie, Fondazione Anna Maria Sechi per il Cuore, Gilead, ICAN, Janssen, Lead-Up, Menarini, Medtronic, MSD, Pfizer, Sanofi-Aventis, Servier, The Medicines Company, TIMI Study Group, and WebMD; S.A. O’Connor, Yan Yan, M. Hauguel-Moreau, M. Zeitouni, P. Overtchouk, A. Ankri, D. Brugier, P. Ecollan, and S. Gallier declare no potential conflicts of interest that might be relevant to this work.